Press Releases from iHealthcareAnalyst, Inc. (555 total)
Global Single Nucleotide Polymorphism Genotyping Market $5 Billion by 2021
The global single nucleotide polymorphism genotyping market is estimated to reach $5 Billion in 2021, growing at a CAGR of 22% from 2017 to 2021, according to a market research report Single Nucleotide Polymorphism Genotyping Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global single nucleotide polymorphism genotyping market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The…
Global Bone and Joint Regenerative Medicines Market $8.2 Billion by 2021
Bone and Joint Regenerative Medicines Market Analysis and Forecast 2017-2021 report estimates the global bone and joint regenerative medicines market to reach nearly $8.2 Billion in 2021, at a CAGR of 11.7% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global bone and joint regenerative medicines market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global bone and joint…
Global Prenatal and Newborn Genetic Testing Market $10.5 Billion by 2021
According to a market research report Prenatal and Newborn Genetic Testing Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global prenatal and newborn genetic testing market is estimated to reach $10.5 Billion in 2021, expanding at a CAGR of 18.0% from 2017 to 2021.
The global prenatal and newborn genetic testing market segmentation is based on technologies (prenatal and newborn genetic diagnostic techniques, array-comparative genomic hybridization, fluorescence in-situ hybridization,…
Global Platelet Rich Plasma (PLP) Market $385 Million by 2021
The global platelet rich plasma (PLP) market is estimated to reach $385 Million in 2021, growing at a CAGR of 11.5% from 2017 to 2021, according to a market research report Platelet Rich Plasma Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global platelet rich plasma market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global platelet…
Global Orthobiologics Market $6.2 Billion by 2021
Orthobiologics Market Analysis and Forecast 2017-2021 report estimates the global orthobiologics market to reach nearly $6.2 Billion in 2021, at a CAGR of 6.2% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global orthobiologics market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global orthobiologics market segmentation is based on product types (allograft, bone morphogenetic proteins, demineralized bone matrix,…
Global Drug Device Combination Products Market $128 Billion by 2021
According to a market research report Drug Device Combination Products Market Analysis and Forecast 2017-2021 published by iHealthcareAnalyst, Inc., the global drug device combination products market is estimated to reach $128 Billion in 2021, expanding at a CAGR of 6.6% from 2017 to 2021.
The global drug device combination products market segmentation is based on device types (drug eluting stents, coronary stents, peripheral vascular stents, infusion pumps, implantable infusion pumps, ambulatory…
Global Anxiety Disorders and Depression Treatment Market $18 Billion by 2021
The global anxiety disorders and depression treatment market is estimated to reach $18 Billion in 2021, growing at a CAGR of 0.9% from 2017 to 2021, according to a market research report Anxiety Disorders and Depression Treatment Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global anxiety disorders and depression treatment market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends…
Global Acute Ischemic Stroke Diagnosis and Treatment Market $1.8 Billion by 2021
Acute Ischemic Stroke Diagnosis and Treatment Market Analysis and Forecast 2017-2021 report estimates the global acute ischemic stroke diagnosis and treatment market to reach nearly $1.8 Billion in 2021, at a CAGR of 5.5% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global acute ischemic stroke diagnosis and treatment market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).…
Global Endoscopic Pelvic Surgery Devices Market US$ 15.8 Billion by 2021 - iHeal …
The global endoscopic pelvic surgery devices market expected to reach US$ 15.8 billion by 2021, growing at CAGR 6.2% over the forecast period 2017-2021, due to technological advancements in endoscopic instrumentation and higher demand for minimally invasive surgeries worldwide. Moreover, significant demand and FDA approvals are likely to boost the global endoscopy devices market, which is estimated to reach US$ 36 billion in 2021, growing at a CAGR of 3.1%…
Global Separation Systems for Commercial Biotechnology Market $15.5 Billion by 2 …
According to a market research report Separation Systems for Commercial Biotechnology Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global separation systems for commercial biotechnology market is estimated to reach $15.5 Billion in 2021, expanding at a CAGR of 5.4% from 2017 to 2021.
The global separation systems for commercial biotechnology market segmentation is based on product types (centrifugation, DNA microarray, electrophoresis, flow cytometry, liquid chromatography, MCAS, FACS, membrane…
Global Transfection Technologies Market $860 Million by 2021
The global transfection technologies market is estimated to reach $860 Million in 2021, growing at a CAGR of 7.8% from 2017 to 2021, according to a market research report Transfection Technologies Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global transfection technologies market segmentation is based on transfection methods (instrument based method, electroporation, biolistic technology, microinjection, laserfection, reagent based method, lipid mediated transfection, calcium phosphate, catonic polymers, DEAE-dextran, activated…
Global Transcriptomics Technologies Market $5.7 Billion by 2021
Transcriptomics Technologies Market Analysis and Forecast 2017-2021 report estimates the global transcriptomics technologies market to reach nearly $5.7 Billion in 2021, at a CAGR of 14.5% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global transcriptomics technologies market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global transcriptomics technologies market segmentation is based on technologies (gene regulation, microarrays, next…
Global Hyaluronic Acid Injections Market $11.4 Billion by 2021
According to a market research report Hyaluronic Acid Injections Market Analysis and Forecast 2017-2021 published by iHealthcareAnalyst, Inc., the global hyaluronic acid injections market is estimated to reach $11.4 Billion in 2021, expanding at a CAGR of 8.8% from 2017 to 2021.
The global hyaluronic acid injections market segmentation is based on product types (single-injection cycle products, three-injection cycle products, five- injection cycle products), applications (osteoarthritis, ophthalmic, dermal fillers, vesicoureteral reflux).…
Global Diagnostic Interventional Cardiology Devices Market US$ 5.6 Billion by 20 …
The global diagnostic interventional cardiology devices market expected to reach US$ 5.6 billion by 2021, growing at CAGR 6.3% over the forecast period 2017-2021, due to increasing preference for minimally invasive procedures, growing geriatric population and higher incidence of cardiovascular diseases worldwide.
The global diagnostic interventional cardiology devices market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021).…
Global Heparin Anticoagulant Market $11.5 Billion by 2021
The global heparin anticoagulant market is estimated to reach $11.5 Billion in 2021, growing at a CAGR of 4.4% from 2017 to 2021, according to a market research report Heparin Anticoagulant Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global heparin anticoagulant market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global heparin anticoagulant market…
Global Glioblastoma Multiforme Drugs Market $890 Million by 2021
Glioblastoma Multiforme Drugs Market Analysis and Forecast 2017-2021 report estimates the global Glioblastoma multiforme drugs market to reach nearly $890 Million in 2021, at a CAGR of 13.4% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global Glioblastoma multiforme drugs market segmentation is based on drug types (Bevacizumab, Temozolomide, Carmustine). The global Glioblastoma multiforme drugs market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts…
Global Chemotherapy-induced Nausea and Vomiting Drugs Market $2 Billion by 2021
According to a market research report Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global chemotherapy-induced nausea and vomiting drugs market is estimated to reach $2 Billion in 2021, expanding at a CAGR of 8.4% from 2017 to 2021.
The global chemotherapy-induced nausea and vomiting drugs market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends…
Global Fragment-based Drug Discovery Market $720 Million by 2021
The global fragment-based drug discovery market is estimated to reach $720 Million in 2021, growing at a CAGR of 10.6% from 2017 to 2021, according to a market research report Fragment-based Drug Discovery Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global fragment-based drug discovery market segmentation is based on service types or components (comparative analysis of FBDD and HTS, fragment screening, biophysical techniques, NMR spectroscopy, DSF assay, fluorescence…
Global Exocrine Pancreatic Insufficiency Diagnostics Market $2.5 Billion by 2021
Exocrine Pancreatic Insufficiency Diagnostics Market Analysis and Forecast 2017-2021 report estimates the global exocrine pancreatic insufficiency diagnostics market to reach nearly $2.5 Billion in 2021, at a CAGR of 8.9% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global exocrine pancreatic insufficiency diagnostics market segmentation is based on diagnostic test types (blood tests, endoscopic ultra-sonography, magnetic resonance imaging, CT scanning). The global exocrine pancreatic insufficiency diagnostics market report provides market size…
Global Nonalcoholic Steatohepatitis Treatment Market to cross $19 Billion by 202 …
According to a market research report Nonalcoholic Steatohepatitis Treatment Market 2015-2025 published by iHealthcareAnalyst, Inc., the global nonalcoholic steatohepatitis treatment market is estimated to cross $19 Billion in 2025, expanding at a CAGR of 10.0% from 2017 to 2025.
The global nonalcoholic steatohepatitis treatment market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global nonalcoholic steatohepatitis treatment…
Global Periodontal Disease Therapeutics Market $175 Million by 2021
The global periodontal disease therapeutics market is estimated to reach $175 Million in 2021, growing at a CAGR of 8.2% from 2017 to 2021, according to a market research report Periodontal Disease Therapeutics Market, Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global periodontal disease therapeutics market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global…
Global Ultraviolet Germicidal Irradiation Market $330 Million by 2021
Ultraviolet Germicidal Irradiation Market Analysis and Forecast 2017-2021 report estimates the global ultraviolet germicidal irradiation market to reach nearly $330 Million in 2021, at a CAGR of 9.9% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global ultraviolet germicidal irradiation market segmentation is based on disinfection type (air disinfection, in-duct air disinfection, recirculation units, upper room systems, surface disinfection, area, room disinfection, equipment and packaging disinfection, lower room disinfection, etc.).
The…
Global Organ Preservation Solutions Market $254 Million by 2021
According to a market research report Organ Preservation Solutions Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global organ preservation solutions market is estimated to reach $254 Million in 2021, expanding at a CAGR of 13.0% from 2017 to 2021.
The global organ preservation solutions market segmentation is based on solution (Viaspan, Custodiol HTK Solution, Renograf, Hypothermosol, Perfadex, Lifor, Human bioSystem solution, siRNA Transplant solution, etc.), and its preservation…
Global Opioid Induced Constipation Drugs Market $2.8 Billion by 2021
The global opioid induced constipation drugs market is estimated to reach $2.8 Billion in 2021, growing at a CAGR of over 25% from 2017 to 2021, according to a market research report Opioid Induced Constipation Drugs Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The global opioid induced constipation drugs market segmentation is based on dosage form of the drug (solid, semi-solid, liquid), and drug classes (Mu opioid receptor antagonist,…
Global Menopausal Hot Flashes Therapy Market $4.9 Billion by 2021
Menopausal Hot Flashes Therapy Market Analysis and Forecast 2017-2021 report estimates the global menopausal hot flashes therapy market to reach nearly $4.9 Billion in 2021, at a CAGR of 3.8% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global menopausal hot flashes therapy market segmentation is based on therapy (hormonal therapy, estrogen, progestin, combination therapy, non-hormonal therapy). The global menopausal hot flashes therapy market report provides market size (Revenue $Million 2014…
Global Human Insulin Market $34.4 Billion by 2021
According to a market research report Human Insulin Market Analysis and Forecast 2017-2021 published by iHealthcareAnalyst, Inc., the global human insulin market is estimated to reach $34.4 Billion in 2021, expanding at a CAGR of 4.8% from 2017 to 2021.
The human insulin market report estimates the market size (Revenue $million - 2014 to 2021) and composition of this market in terms of five product classes such as slow-acting, fast-acting, long-acting,…
Global Metabolomics Market $1.4 Billion by 2021
The global metabolomics market is estimated to reach $1. 4 Billion in 2021, growing at a CAGR of 15.6% from 2017 to 2021, according to a market research report Metabolomics Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
The metabolomics market report estimates the market size (Revenue $million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug…
Global Albumin Market $307 Million by 2021
According to a market research report Albumin Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach $307 Million in 2021, expanding at a CAGR of 2.4% from 2017 to 2021.
The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market…
Global Nanomedicine Market $185 Billion by 2021
The global nanomedicine market is estimated to reach $185 Billion in 2021, growing at a CAGR of 8.9% from 2017 to 2021, according to a market research report Nanomedicine Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc.
Visit the Nanomedicine Market Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/nanomedicine-market/
Nanomedicine is the medical application of nanotechnology that ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and…
Radiopharmaceuticals Market $376 Million by 2021
Radiopharmaceuticals Market Analysis and Forecast 2017-2021 report estimates the global radiopharmaceuticals market to reach nearly $376 Million in 2021, at a CAGR of 4.9% from 2017 to 2021 - iHealthcareAnalyst, Inc.
The global radiopharmaceuticals market report estimates the market size (Revenue $million - 2014 to 2021) for key market segments based on the indications (cardiovascular, oncology, neurological, thyroid, gastrointestinal, etc.), therapeutics (systemic oncology using Iodine, Yttrium, Samarium, Strontium, Rhenium, Lutetium, Erbium;…
Global Spinal Cord Stimulation Devices Market US$ 2.4 Billion by 2021 According …
The global spinal cord stimulation devices market expected to reach US$ 2.4 billion by 2021, growing at CAGR 5.7% over the forecast period 2017-2021, due to fast advancing applications and technologies, allowing more effective and individualized treatment for patients.
The global spinal cord stimulation devices market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global spinal…
Global Antibody Drug Conjugates Market US$ 4.6 Billion by 2021
The global antibody drug conjugates market expected to reach US$ 4.6 billion by 2021, growing at CAGR 30.2% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments.
Read our PR here: https://www.ihealthcareanalyst.com/global-antibody-drug-conjugates-market/
Visit Antibody Drug Conjugates Market by Marketed Drugs - Adcetris or SGN-35 (Brentuximab vedotin), Kadcyla or T-DM1 (Trastuzumab emtansine), Pipeline Drugs - Rova-T or SC16LD6.5 (Rovalpituzumab tesirine), CDX‑011 (Glembatumumab vedotin), Besponsa or CMC-544…
Global Antibody Drug Conjugates Market US$ 4.6 Billion by 2021
The global antibody drug conjugates market expected to reach US$ 4.6 billion by 2021, growing at CAGR 30.2% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments.
In the quest for more targeted therapies and potentially more clinically efficacious drugs, bio/pharmaceutical companies are increasing their research and product development in biologics. Antibody–drug conjugates (ADCs), which consist of a mAb chemically linked to a small-molecule…
Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market US$ 3.5 Billion by 2 …
The global idiopathic pulmonary fibrosis treatment market expected to reach US$ 3.5 billion by 2021, growing at CAGR 14.4% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments.
Visit Idiopathic Pulmonary Fibrosis (IPF) Treatment Market by Treatment Type - Pharmacological Treatment (Pirfenidone (Esbriet), Nintedanib (Ofev), Generic Pirfenidone); Non-pharmacological Treatment (Oxygen Therapy, Pulmonary Rehabilitation, Mechanical Ventilation, Lung Transplantation, Other Non-Pharmacological Treatment); Patients by Disease Severity…
Global Acute Myeloid Leukemia (AML) Treatment Market US$ 1.17 Billion 2021
Acute myeloid leukemia (AML) is the second most common type of leukemia diagnosed in adults and children. In 2017, in the United States, an estimated 21,380 people will be diagnosed with AML.
The global acute myeloid leukemia treatment market expected to reach US$ 1.17 billion by 2021, growing at CAGR 15% over the forecast period 2017-2021, owing to introduction of high-priced products and strong pipeline of upcoming drugs. During…
Global Opioid Induced Constipation Drugs Market US$ 2.8 Billion by 2021
The global equine healthcare market estimated to reach US$ 2.8 Billion by 2021, at a CAGR of 31% from 2017 to 2021. Increasing number of chronic pain patients, growing acceptance of opioid to treat pain, and launch of new drugs to treat opioid induced constipation are major factors expected to drive the global opioid induced constipation drugs market during the forecast period.
Browse Opioid Induced Constipation Drugs Market by Dosage Form…
Global Nonalcoholic Steatohepatitis (NASH) Treatment Market US$ 19.8 Billion by …
The global nonalcoholic steatohepatitis (NASH) treatment market is estimated to reach US$ 19.8 Billion in 2025, expanding at a CAGR of 10.0% from 2017 to 2025, mainly driven by expected approval of Aramchol, Elafibranor, Obeticholic acid, and Simtuzumab, and introduction of several new high-priced products. Moreover, combination therapies are likely to dominate the global market over the forecast period.
https://www.ihealthcareanalyst.com/global-nonalcoholic-steatohepatitis-treatment-market/
No medicines have been approved to treat NAFLD and NASH.…
Global Anxiety Disorders and Depression Treatment Market US$ 18 Billion by 2021
The global anxiety disorders and depression treatment market is estimated to reach US$ 18 Billion in 2021, growing at a CAGR of 0.9% from 2017 to 2021,
Anxiety disorders and depression are different, but people with depression often experience symptoms similar to those of an anxiety disorder, such as nervousness, irritability, and problems sleeping and concentrating. Depression is a mood disorder with a multitude of symptoms, including lowered mood, fatigue…
Global Primary Immunodeficiency Diseases Market US$ 6.1 Billion by 2021
The global primary immunodeficiency diseases market expected to reach US$ 6.1 billion by 2021, growing at CAGR 6.7% over the forecast period 2017-2021, due to higher incidence of primary immunodeficiency disorders worldwide.
Primary immunodeficiency diseases or disorders (PIDD or PI) are caused as part of the body's immune system is missing or does not function normally, such that it is an inherited flaw in the immune system that increases the…
Global Equine Healthcare Market US$ 21.3 Billion by 2021 (update)
The global equine healthcare market estimated to reach US$ 21.3 Billion by 2021, at a CAGR of -1.8% from 2017 to 2021, mainly due to increasing aging population, declining overall equine population, industry fragmentation, high cost of healthcare, feed, and supplements. However, according to 2015 AHP equine industry survey, the equine industry has found stability and shows positive signs of growth during the forecast period. By geography, in 2016, North…
Global Equine Health Products Market to US$ 21.3 Million by 2021
The global equine health care market estimated to reach US$ 21.3 Million by 2021, at a CAGR of -1.8% from 2017 to 2021.
Visit Equine Healthcare Market by Diagnostic Products (Genotyping Analysis, Quality Analyzers/Genotype Analyzers Kits, Genetic Disease Identification Products, Pregnancy and Gestation, UltraSound Devices, Urine Test Kits), Therapeutic Products (Antibacterials, Anti-inflammatory Drugs, Antiprotozoals, Antivirals, Dopamine Agonists, Laxatives, Vaccines), and Supplement Products (Performance Supplements, Electrolyte Supplements, Proteins and Amino Acids…
U.S. Therapeutic Interventional Cardiology Devices Market US$ 2.64 Billion by 20 …
The U.S. therapeutic interventional cardiology devices market expected to reach US$ 2.64 billion by 2021, growing at CAGR 0.2% over the forecast period 2017-2021.
For more details on U.S. Therapeutic Interventional Cardiology Devices Market by Devices Type (Coronary Stent Systems, Percutaneous Transluminal Coronary Angioplasty Devices, Coronary Atherectomy Systems - Laser Atherectomy Systems, Mechanical Atherectomy Systems, ¬Transcatheter Septal Defect Repair Devices, ¬Coronary Thrombectomy Systems) and Forecast 2017-2021, contact us at https://www.ihealthcareanalyst.com/contact/
The…
Global Inhalation Drug Delivery Devices Market US$ 14.9 Billion by 2021
The global inhalation drug delivery devices market expected to reach US$ 14.9 billion by 2021, growing at CAGR 1.2% over the forecast period 2017-2021, owing to rising prevalence of asthma, cystic fibrosis, and chronic obstructive pulmonary disease worldwide. North America accounted for the highest 54.8% share, followed by Europe 12.8% share of the global market. The key driving factors for growth include generic erosion, increasing incidence of pulmonary diseases and…
Global Biopsy Devices Market US$ 2.2 billion by 2021
The global biopsy devices market expected to reach US$ 2.2 billion by 2021, growing at CAGR 5.8% over the forecast period 2017-2021, owing to increased rates of cancer, higher preference for minimal invasive technologies and rising geriatric population worldwide.
Browse Biopsy Devices Market by Product Types (Needle-Based Guns -Vacuum-Assisted, Core Needle, Fine Needle Aspiration; Biopsy Needles – Disposable, Reusable; Biopsy Forceps – Cold and Hot; Guidance Systems – Manual and…
Global Stem Cell Therapy Market US$ 7.7 billion by 2021 (Updated)
The global stem cell therapy market expected to reach US$ 7.7 billion by 2021, growing at CAGR 10.6% over the forecast period 2017-2021, owing to advancement in human development, genetic and chromosomal disorders, human reproduction, and new disease therapies.
The global stem cells market was approximately 13 billion dollars in 2016, and from 2017, the expected annual growth rate is 14.7%, which would expand the market to 29.6 billion dollars by…
Global Stem Cell Therapy Market US$ 14.7 billion by 2021
The global stem cell therapy market expected to reach US$ 14.7 billion by 2021, growing at CAGR 10.6% over the forecast period 2017-2021, owing to advancement in human development, genetic and chromosomal disorders, human reproduction, and new disease therapies.
Stem cells are being studied for a number of medical applications such as neurodegeneration, brain and spinal cord injury, generation of heart muscle cells, blood-cell formation, re-growing teeth, cochlear hair cell regrowth,…
Global Head and Neck Squamous Cell Carcinoma Drugs Market US$ 1.5 Billion 2021
The global head and neck squamous cell carcinoma drugs market expected to reach US$ 1.5 billion by 2021, growing at CAGR 23.5% over the forecast period 2017-2021, mainly due to rising epidemic of oropharynx cancer associated with the human papillomavirus.
The management of advanced Head and neck squamous cell carcinoma (HNSCC) consists of multiple-modality therapy with surgery, radiation, and chemotherapy. Palliative radiation therapy is beneficial for treating symptomatic metastatic sites. Selective…
Global Rheumatoid Arthritis Drugs Market US$ 36.6 billion by 2021
The global rheumatoid arthritis drugs market expected to reach US$ 36.3 billion by 2021, growing at CAGR 8.5% over the forecast period 2017-2021, mainly due to number of promising RA therapies are in development and drug approvals.
Rheumatoid arthritis (RA) is a chronic autoimmune condition of the connective tissue in synovial joints characterized by inflammation that can lead to impaired movement and disability. Small-molecule disease-modifying anti-rheumatic drugs (DMARDs) DMARDs include methotrexate…
Global Genomic Sequencing Technologies Market US$ 7.2 Billion by 2021
The global genomic sequencing technologies market expected to reach US$ 7.2 billion by 2021, growing at CAGR 14% over the forecast period 2017-2021, mainly due to high-throughput - next generation sequencing technologies, and advances in personalized medicine.
Genomic sequencing technologies have revolutionized biology, with impacts ranging from the sequencing of several model genomes to the birth of a new era for pharmacogenomics. In recent years, there has been an increasing fragmentation…
Global Heart Valve Repair and Replacement Devices Market US$ 8.1 Billion by 2021
The global heart valve repair and replacement devices market expected to reach US$ 8.1 billion by 2021, growing at CAGR 10.2% over the forecast period 2017-2021, mainly due to new device approvals, technological advancements, and rising geriatric population.
Heart valve repair or replacement surgeries are performed for damaged or diseased valves that may cause heart valve dysfunction (valve stenosis) and valve regurgitation (leaky valve). Heart valve repair is a surgical technique…
